Results 111 to 120 of about 75,591 (303)

Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions

, 2017
The prevalence of risky opioid use, opioid use disorder, and related harms continue to rise among youth (adolescents and young adults age 15-25) in North America.
Jan Klimas, Wood, Evan, Derek C. Chang, Evan Wood, Chang, Derek C, Chang, Derek, Fairbairn, Nadia, Nadia Fairbairn, Klimas, Jan   +8 more
core   +1 more source

Implantable drug delivery system: Frontiers of medicine‐engineering interdisciplinary

Interdisciplinary Medicine, EarlyView.
This review systematically summarizes the driving mechanisms of implantable on‐demand drug delivery systems (IDDS), including endogenous, exogenous, and closed‐loop strategies. It highlights the pivotal roles of flexible electronics and miniaturization in enhancing the tissue conformity and spatial adaptability.
Yu Zeng, Rongtai Su, Manyu Zhao, Xin Song, Ran Liu, Yuhao Zhou, Chaojuan Yang, Yanli Jiao, Xiao‐Wei Xiang, Lingqian Chang   +9 more
wiley   +1 more source

Assessment and evidence-based treatments for opioid use disorder [PDF]

Clinician Outreach and Communication Activity (COCA) conference call Tuesday, November 29, 2016.One substantial risk associated with prescribing opioids for chronic pain is opioid use disorder (OUD).

core  

Things We Do for No Reason™: Withholding opioids among patients with acute pain and opioid use disorder

Journal of Hospital Medicine, EarlyView.
Abstract Hospitalists care for patients with acute pain who have an opioid use disorder and require pain management. Hospitalists may withhold opioids for acute pain due to a variety of reasons. However, adequate pain management in patients with opioid use disorder, including with opioids, is the standard of care. This piece explains how to best manage
Anna‐Maria South, Susan L. Calcaterra, Marlene Martin   +2 more
wiley   +1 more source

Clinical Impact of an Expanded MOUD Access Initiative for Patients Hospitalized With Infections From Intravenous Opioid Use

American Journal of Medicine Open
Background: Despite their efficacy, medications for opioid use disorder (MOUD) remain underutilized in patients with infections from intravenous opioid use (I-IOU).
Jack Keegan, William Peppard, Rebecca Bauer, Mary Beth Alvarez, Kimberly Stoner, Jennifer McNeely   +5 more
doaj   +1 more source

Addressing the unique challenges of opioid use disorder in women [PDF]

Tuesday, January 17, 2017 at 1 p.m. ESTDeaths from drug overdoses are the number one cause of injury death in the U.S. Most of these deaths are related to the misuse of prescription opioids and heroin.

core  

Patient and hospitalization differences in incarcerated versus nonincarcerated men: Insights from a 10‐year cohort study

Journal of Hospital Medicine, EarlyView.
Abstract Background The incarcerated population in the United States is underserved and aging rapidly; there is a dearth of information regarding their health, including hospital care. Epidemiological information is crucial to guide policymakers’ planning.
Farah Acher Kaiksow, Amir Forati, Kristin Merss, Karen Reece, Marguerite Burns, Eduard Eric Vasilevskis   +5 more
wiley   +1 more source

Low-dose overlap initiation with split tablets of buprenorphine in intubated intensive care unit patients with opioid use disorder

Harm Reduction Journal
Background As the opioid public health crisis evolves to include fentanyl and other potent synthetic opioids, more patients are admitted to the hospital with serious complications of drug use and frequently require higher levels of care, including ...
Laura Szczesniak, Sarah Britton, Theresa Baxter RN, Ross Sullivan   +3 more
doaj   +1 more source

A review of leveraging artificial intelligence to predict persistent postoperative opioid use and opioid use disorder and its ethical considerations.

PURPOSE OF REVIEW: Artificial intelligence (AI) offers a new frontier for aiding in the management of both acute and chronic pain, which may potentially transform opioid prescribing practices and addiction prevention strategies. In this review paper, not
Macias, Alvaro A, Gabriel, Rodney A, Hsu, Chun-Nan, Park, Brian H   +3 more
core   +1 more source

Evaluating Sleep Apnea: In‐Lab Versus at‐Home Recording Time and the Impact of Positional Disease

The Laryngoscope, EarlyView.
We evaluated the minimum recording time needed for in‐lab polysomnography (PSG1) and home sleep apnea test Type 3 portable monitoring (HSAT) to accurately reflect the full‐night apnea–hypopnea index (AHI) in patients with suspected obstructive sleep apnea (OSA).
Raquel Chartuni Pereira Teixeira, Michel Burihan Cahali   +1 more
wiley   +1 more source